Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.
about
Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDSSexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men.Risk behavior-based model of the cubic growth of acquired immunodeficiency syndrome in the United States.The natural history of human T lymphotropic virus-III infection: the cause of AIDS.The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibodyThe Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathyVariation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).AIDS and the gay community: the doctor's role in counselling.Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.Trends in incidence of anal cancer in DenmarkOral sex and the transmission of viral STIsRecent increase in the incidence of non-Hodgkin's lymphoma among young men and women in DenmarkTracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.Immunological study of the rectal mucosa of men with and without human immunodeficiency virus infection.
P2860
Q33583156-88A75D74-3323-4FCC-B323-B64D954281AFQ33583401-419B9E7A-FB3A-4442-A382-B7175D88FFE0Q33864846-D3F9E1C0-6BF2-4297-85CB-2169208DBFB5Q34282439-274FE99F-4565-455D-9D5A-CE250E3EB22CQ34299582-F3FA4AE2-83E4-48F9-9FB8-FE323F6DF353Q34299646-335D84B9-D04E-4BD2-B1F3-F073570EA0F6Q34300221-65D9DA35-9B92-40AC-A76D-8FDB7A546733Q34487435-63991C60-A74C-4BE0-BF87-1F7FD90C60B5Q34488340-FBC99372-9E01-48AB-8735-2ED5A295D3EAQ34491550-D4D2F962-F0EB-454A-8F2F-98EFEB4A0A0AQ34729798-98F9CB56-41A3-4066-88C8-6BF520C118A9Q35170201-6AC27DEC-DB37-45CF-AA9E-4819199374ABQ35186242-1535074C-328A-44C5-AD7D-B77C043278BEQ35562031-FB6457BD-FBE9-44F9-85CC-3CEC6555A29CQ36134246-79B30924-8C5A-4EA3-8251-A0C6E379CFBAQ37278724-93578D80-8E9E-4A8B-A515-5D9C8AD59AE7Q41522139-D8A2C165-CCE6-459F-9B0B-3DC8992F0642Q43193379-247DEEFB-5A9A-495A-B60D-DF8452A4A552
P2860
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@ast
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@en
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@nl
type
label
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@ast
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@en
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@nl
prefLabel
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@ast
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@en
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@nl
P2093
P2860
P1433
P1476
Seroepidemiology of HTLV-III a ...... smission, and disease outcome.
@en
P2093
M G Sarngadharan
R J Biggar
W A Blattner
P2860
P304
P407
P577
1984-09-01T00:00:00Z